Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,6,0.94 [0.91-0.98],0.00242996620468525,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,6,0.62 [0.44-0.87],0.0056620627660907,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,6,0.94 [0.88-1],0.0342125900150759,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LOWBACKPAIN,Inverse variance weighted,6,0.94 [0.88-1],0.0541974929455229,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,6,0.83 [0.67-1.02],0.0715798733771034,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_MUSCULOSKELETAL,Inverse variance weighted,4,1.05 [0.98-1.12],0.183207990867775,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIV Diseases of the genitourinary system,N14_PROSTHYPERPLA,Inverse variance weighted,6,1.05 [0.97-1.13],0.244162323919874,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XI Diseases of the digestive system,K11_REFLUX,Inverse variance weighted,6,0.95 [0.85-1.05],0.31985429429837,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,6,0.98 [0.94-1.02],0.339925029523803,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter II Neoplasms,C3_PROSTATE_EXALLC,Inverse variance weighted,6,1.05 [0.94-1.17],0.386505923503627,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,6,0.98 [0.94-1.03],0.406645946295619,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,6,0.98 [0.93-1.03],0.470163226626334,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIV Diseases of the genitourinary system,N14_GENITOURINARY,Inverse variance weighted,4,1.02 [0.97-1.06],0.491954846102857,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,6,0.9 [0.64-1.26],0.526108360541412,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIV Diseases of the genitourinary system,N14_MALEGEN,Inverse variance weighted,6,1.02 [0.96-1.08],0.611719400831742,cis
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,21,0.97 [0.95-0.99],0.000765055094805571,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,21,1.04 [1.01-1.08],0.0189464271464161,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,21,1.02 [1-1.05],0.0260768048436756,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter II Neoplasms,C3_PROSTATE_EXALLC,Inverse variance weighted,21,1.12 [0.99-1.27],0.0606403088524738,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,21,1.02 [1-1.05],0.0672232234723944,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,21,0.96 [0.9-1.02],0.198233928608924,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,21,0.88 [0.72-1.09],0.242582997810485,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,21,0.99 [0.96-1.02],0.438489161758033,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XI Diseases of the digestive system,K11_REFLUX,Inverse variance weighted,21,1.02 [0.97-1.07],0.457576977115858,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LOWBACKPAIN,Inverse variance weighted,21,1.01 [0.98-1.05],0.478610340191123,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIV Diseases of the genitourinary system,N14_PROSTHYPERPLA,Inverse variance weighted,21,0.99 [0.95-1.03],0.679735940935261,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,21,1.04 [0.87-1.24],0.702831093219229,trans
GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Chapter XIV Diseases of the genitourinary system,N14_MALEGEN,Inverse variance weighted,21,1 [0.97-1.04],0.877376723724376,trans
